BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15100292)

  • 1. Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.
    Velloso LM; Michaëlsson J; Ljunggren HG; Schneider G; Achour A
    J Immunol; 2004 May; 172(9):5504-11. PubMed ID: 15100292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex.
    Tissot AC; Ciatto C; Mittl PR; Grütter MG; Plückthun A
    J Mol Biol; 2000 Sep; 302(4):873-85. PubMed ID: 10993729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of tyrosine to the inflammation-associated analog 3'-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells.
    Hardy LL; Wick DA; Webb JR
    J Immunol; 2008 May; 180(9):5956-62. PubMed ID: 18424715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2D Kinetic Analysis of TCR and CD8 Coreceptor for LCMV GP33 Epitopes.
    Kolawole EM; Andargachew R; Liu B; Jacobs JR; Evavold BD
    Front Immunol; 2018; 9():2348. PubMed ID: 30374353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb.
    Puglielli MT; Zajac AJ; van der Most RG; Dzuris JL; Sette A; Altman JD; Ahmed R
    J Virol; 2001 Jun; 75(11):5099-107. PubMed ID: 11333891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics.
    Allerbring EB; Duru AD; Uchtenhagen H; Madhurantakam C; Tomek MB; Grimm S; Mazumdar PA; Friemann R; Uhlin M; Sandalova T; Nygren PÅ; Achour A
    Eur J Immunol; 2012 Nov; 42(11):2990-3000. PubMed ID: 22837158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells.
    Gallimore A; Hombach J; Dumrese T; Rammensee HG; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Oct; 28(10):3301-11. PubMed ID: 9808199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structural basis for LCMV immune evasion: subversion of H-2D(b) and H-2K(b) presentation of gp33 revealed by comparative crystal structure.Analyses.
    Achour A; Michaëlsson J; Harris RA; Odeberg J; Grufman P; Sandberg JK; Levitsky V; Kärre K; Sandalova T; Schneider G
    Immunity; 2002 Dec; 17(6):757-68. PubMed ID: 12479822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-associated nitrotyrosination affects TCR recognition through reduced stability and alteration of the molecular surface of the MHC complex.
    Madhurantakam C; Duru AD; Sandalova T; Webb JR; Achour A
    PLoS One; 2012; 7(3):e32805. PubMed ID: 22431983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTL escape viral variants. I. Generation and molecular characterization.
    Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
    Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area.
    Goyarts EC; Vegh Z; Kalergis AM; Hörig H; Papadopoulos NJ; Young AC; Thomson CT; Chang HC; Joyce S; Nathenson SG
    Mol Immunol; 1998 Jul; 35(10):593-607. PubMed ID: 9823758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and biological basis of CTL escape in coronavirus-infected mice.
    Butler NS; Theodossis A; Webb AI; Dunstone MA; Nastovska R; Ramarathinam SH; Rossjohn J; Purcell AW; Perlman S
    J Immunol; 2008 Mar; 180(6):3926-37. PubMed ID: 18322201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidic termini play a significant role in TCR recognition.
    Wang B; Sharma A; Maile R; Saad M; Collins EJ; Frelinger JA
    J Immunol; 2002 Sep; 169(6):3137-45. PubMed ID: 12218131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structural basis for CD8+ T cell-dependent recognition of non-homologous peptide ligands: implications for molecular mimicry in autoreactivity.
    Sandalova T; Michaëlsson J; Harris RA; Odeberg J; Schneider G; Kärre K; Achour A
    J Biol Chem; 2005 Jul; 280(29):27069-75. PubMed ID: 15845547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison.
    Storni T; Bachmann MF
    J Immunol; 2004 May; 172(10):6129-35. PubMed ID: 15128799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes.
    Gairin JE; Mazarguil H; Hudrisier D; Oldstone MB
    J Virol; 1995 Apr; 69(4):2297-305. PubMed ID: 7533855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
    Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
    J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
    Storni T; Lechner F; Erdmann I; Bächi T; Jegerlehner A; Dumrese T; Kündig TM; Ruedl C; Bachmann MF
    J Immunol; 2002 Mar; 168(6):2880-6. PubMed ID: 11884458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
    Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
    Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.